No, you didn't, actually. We've got some models here on primary care whereby we've been able to deploy very rapidly—like a rapid prototype—the program. It would mean getting the program from the U.S. so that it's on a Canadian server. It would mean being able to have it available within the practices where people go. For anyone coming in for a pain prescription, they would have to go through this model that would assess their risk of abuse or misuse. It would detect any misuse, and then provide the practitioner and the patient with opportunities to make decisions jointly as to what treatment happens.
At the back end, this data, if it's done in enough clinics, as has been shown in the U.S.—in fact it was that model that actually showed when the OxyContin shifts were occurring—when you collate that data, you can very quickly get a sense. If you had this across the country in clinics, you would very quickly get a sense of what problems and trends were going on. You'd be actually integrating your clinical treatments with your data collection, with your analysis. There's benefit to the practice, the patient, the administrators, and the funding decision-makers.
It's a new way of thinking about health care delivery. It's difficult to make inroads like that in Canada, but I think we can with the appropriate supports.